Achieve Life Sciences Inc
NASDAQ:ACHV

Watchlist Manager
Achieve Life Sciences Inc Logo
Achieve Life Sciences Inc
NASDAQ:ACHV
Watchlist
Price: 3.69 USD -3.4% Market Closed
Market Cap: 126.7m USD
Have any thoughts about
Achieve Life Sciences Inc?
Write Note

Intrinsic Value

ACHV's intrinsic value estimate is unreliable because it is based only on its DCF value and doesn't use a relative valuation using multiples.

The intrinsic value of one ACHV stock under the Base Case scenario is 5.1 USD. Compared to the current market price of 3.69 USD, Achieve Life Sciences Inc is Undervalued by 28%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

ACHV Intrinsic Value
5.1 USD
Undervaluation 28%
Intrinsic Value
Price
Base Case Scenario

Valuation History
Achieve Life Sciences Inc

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Valuation History Unavailable

Historical valuation for ACHV cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
How do you feel about ACHV?
Bearish
Neutral
Bullish

Fundamental Analysis

3.69 USD
-3.4%
-3.4%
Benchmark
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Achieve Life Sciences Inc
US
Biotechnology
Market Cap
126.9m USD
IPO
Oct 12, 1995
Employees
16
United States of America
Market Cap
126.9m USD
Industry
Biotechnology
IPO
Oct 12, 1995
Company Overview
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about Achieve Life Sciences Inc

Provide an overview of the primary business activities
of Achieve Life Sciences Inc.

What unique competitive advantages
does Achieve Life Sciences Inc hold over its rivals?

What risks and challenges
does Achieve Life Sciences Inc face in the near future?

Has there been any significant insider trading activity
in Achieve Life Sciences Inc recently?

Summarize the latest earnings call
of Achieve Life Sciences Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Achieve Life Sciences Inc.

Provide P/S
for Achieve Life Sciences Inc.

Provide P/E
for Achieve Life Sciences Inc.

Provide P/OCF
for Achieve Life Sciences Inc.

Provide P/FCFE
for Achieve Life Sciences Inc.

Provide P/B
for Achieve Life Sciences Inc.

Provide EV/S
for Achieve Life Sciences Inc.

Provide EV/GP
for Achieve Life Sciences Inc.

Provide EV/EBITDA
for Achieve Life Sciences Inc.

Provide EV/EBIT
for Achieve Life Sciences Inc.

Provide EV/OCF
for Achieve Life Sciences Inc.

Provide EV/FCFF
for Achieve Life Sciences Inc.

Provide EV/IC
for Achieve Life Sciences Inc.

Show me price targets
for Achieve Life Sciences Inc made by professional analysts.

What are the Revenue projections
for Achieve Life Sciences Inc?

How accurate were the past Revenue estimates
for Achieve Life Sciences Inc?

What are the Net Income projections
for Achieve Life Sciences Inc?

How accurate were the past Net Income estimates
for Achieve Life Sciences Inc?

What are the EPS projections
for Achieve Life Sciences Inc?

How accurate were the past EPS estimates
for Achieve Life Sciences Inc?

What are the EBIT projections
for Achieve Life Sciences Inc?

How accurate were the past EBIT estimates
for Achieve Life Sciences Inc?

Compare the revenue forecasts
for Achieve Life Sciences Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Achieve Life Sciences Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Achieve Life Sciences Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Achieve Life Sciences Inc compared to its peers.

Compare the P/E ratios
of Achieve Life Sciences Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Achieve Life Sciences Inc with its peers.

Analyze the financial leverage
of Achieve Life Sciences Inc compared to its main competitors.

Show all profitability ratios
for Achieve Life Sciences Inc.

Provide ROE
for Achieve Life Sciences Inc.

Provide ROA
for Achieve Life Sciences Inc.

Provide ROIC
for Achieve Life Sciences Inc.

Provide ROCE
for Achieve Life Sciences Inc.

Provide Gross Margin
for Achieve Life Sciences Inc.

Provide Operating Margin
for Achieve Life Sciences Inc.

Provide Net Margin
for Achieve Life Sciences Inc.

Provide FCF Margin
for Achieve Life Sciences Inc.

Show all solvency ratios
for Achieve Life Sciences Inc.

Provide D/E Ratio
for Achieve Life Sciences Inc.

Provide D/A Ratio
for Achieve Life Sciences Inc.

Provide Interest Coverage Ratio
for Achieve Life Sciences Inc.

Provide Altman Z-Score Ratio
for Achieve Life Sciences Inc.

Provide Quick Ratio
for Achieve Life Sciences Inc.

Provide Current Ratio
for Achieve Life Sciences Inc.

Provide Cash Ratio
for Achieve Life Sciences Inc.

What is the historical Revenue growth
over the last 5 years for Achieve Life Sciences Inc?

What is the historical Net Income growth
over the last 5 years for Achieve Life Sciences Inc?

What is the current Free Cash Flow
of Achieve Life Sciences Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Achieve Life Sciences Inc.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Achieve Life Sciences Inc

Current Assets 45.5m
Cash & Short-Term Investments 42.9m
Other Current Assets 2.6m
Non-Current Assets 2.4m
PP&E 20k
Intangibles 2.1m
Other Non-Current Assets 304k
Current Liabilities 6.7m
Accounts Payable 1m
Accrued Liabilities 5m
Other Current Liabilities 699k
Non-Current Liabilities 9.8m
Long-Term Debt 9.8m
Efficiency

Earnings Waterfall
Achieve Life Sciences Inc

Revenue
0 USD
Operating Expenses
-31.3m USD
Operating Income
-31.3m USD
Other Expenses
-1.7m USD
Net Income
-32.9m USD

Free Cash Flow Analysis
Achieve Life Sciences Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

ACHV Profitability Score
Profitability Due Diligence

Achieve Life Sciences Inc's profitability score is 23/100. The higher the profitability score, the more profitable the company is.

23/100
Profitability
Score

Achieve Life Sciences Inc's profitability score is 23/100. The higher the profitability score, the more profitable the company is.

ACHV Solvency Score
Solvency Due Diligence

Achieve Life Sciences Inc's solvency score is 63/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Negative Net Debt
Low D/E
Long-Term Solvency
63/100
Solvency
Score

Achieve Life Sciences Inc's solvency score is 63/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

ACHV Price Targets Summary
Achieve Life Sciences Inc

Wall Street analysts forecast ACHV stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ACHV is 16.32 USD with a low forecast of 10.1 USD and a high forecast of 31.5 USD.

Lowest
Price Target
10.1 USD
174% Upside
Average
Price Target
16.32 USD
342% Upside
Highest
Price Target
31.5 USD
754% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for ACHV?

Click here to dive deeper.

Dividends

Achieve Life Sciences Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for ACHV is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

ACHV Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

See Also

Discover More
What is the Intrinsic Value of one ACHV stock?

The intrinsic value of one ACHV stock under the Base Case scenario is 5.1 USD.

Is ACHV stock undervalued or overvalued?

Compared to the current market price of 3.69 USD, Achieve Life Sciences Inc is Undervalued by 28%.

Back to Top